Company
Gilead Sciences Inc GILD
Tracked across 9 disclosed holders on Protégé.
5 tracked investors, latest 13F quarter ending 30 Jun 2026 · 3 members of Congress · 1 executive · latest filing 2 Oct 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Holocene Advisors | 0.9% | $406.4M | 2026-06-30 |
| Squarepoint Capital | 0.5% | $230.3M | 2026-06-30 |
| Renaissance Technologies | 0.4% | $280.1M | 2026-06-30 |
| Ken Griffin | 0.3% | $439.7M | 2026-06-30 |
| Brevan Howard Asset Management | 0.2% | $15.6M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Jared Moskowitz | 2 buys / 0 sells | $16K |
| Josh Gottheimer | 1 buy / 0 sells | $8K |
| Marjorie Greene | 1 buy / 0 sells | $8K |
Company executives who disclosed trades
| Executive | Disclosed activity | Net |
|---|---|---|
| Daniel O'Day | 0 buys / 19 sells | -$58.0M |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.